Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Data reduction and representation in drug discovery.

Trevor J Howe1, Guy Mahieu, Patrick Marichal

  • 1Johnson & Johnson Pharmaceutical Research & Development, Janssen Pharmaceutica N.V., Turnhoutseweg 30, B-2340 Beerse, Belgium. thowe@prdbe.jnj.com

Drug Discovery Today
|January 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimizing the performance of in silico ADMET general models according to local requirements: MARS approach. solubility estimations as case study.

Journal of chemical information and modeling·2009
Same author

Advanced biological and chemical discovery (ABCD): centralizing discovery knowledge in an inherently decentralized world.

Journal of chemical information and modeling·2007
Same author

Pyrrolo[1,2-a][1,4]benzodiazepine: a novel class of non-azole anti-dermatophyte anti-fungal agents.

Bioorganic & medicinal chemistry letters·2005
Same author

REALISIS: a medicinal chemistry-oriented reagent selection, library design, and profiling platform.

Journal of chemical information and computer sciences·2004
Same author

The novel azole R126638 is a selective inhibitor of ergosterol synthesis in Candida albicans, Trichophyton spp., and Microsporum canis.

Antimicrobial agents and chemotherapy·2004
Same author

Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.

Microbiology (Reading, England)·1999
Same journal

Validation of AI-enabled surrogate models in quantitative systems pharmacology: a practical, context-of-use-driven review.

Drug discovery today·2026
Same journal

IdopNetworks: How to infer the individualized genetic architecture of genomics for precision medicine.

Drug discovery today·2026
Same journal

Organoid-AI platforms need integrated governance in drug discovery.

Drug discovery today·2026
Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026
Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026
Same journal

From biologics to small-molecule modulators: the evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
See all related articles

Making sense of complex pre-clinical drug discovery data requires intuitive visualization methods. This approach enhances decision-making by presenting multivariate information in an interpretable format, bridging biosciences and visual psychology.

Area of Science:

  • Drug discovery and development
  • Bioinformatics and cheminformatics
  • Data visualization

Background:

  • Pre-clinical drug discovery generates vast, inter-related multivariate datasets.
  • Interpreting this complex data is crucial for effective decision-making.
  • Traditional data reduction methods can result in overly complex datasets.

Purpose of the Study:

  • To highlight the need for intuitive visualization methods in pre-clinical drug discovery.
  • To address the challenges posed by high-dimensional, multivariate data.
  • To emphasize the role of visualization in making complex data interpretable.

Main Methods:

  • Review of data visualization techniques in bioinformatics and cheminformatics.
  • Discussion of the challenges in interpreting reduced-dimension datasets.

Related Experiment Videos

  • Exploration of the interdisciplinary nature of data visualization.

    • Main Results:

    • Intuitive visualization is essential for understanding complex pre-clinical data.
    • Bioinformatics and cheminformatics are key drivers in developing visualization tools.
    • Data visualization facilitates better decision-making in drug discovery.

    Conclusions:

    • Visualization is a critical, burgeoning field in pre-clinical drug discovery.
    • Effective visualization bridges biosciences, mathematics, and visual psychology.
    • Interpretable data presentation is paramount for advancing drug discovery.